Today: 7 February 2026
Subscribe
Browse Category

Mergers & Acquisitions News 18 November 2025 - 21 November 2025

Metsera (MTSR) News Today, 21 November 2025: Pfizer’s $10 Billion Buyout, $6 Billion Bond Sale and What It Means for Investors

Metsera (MTSR) News Today, 21 November 2025: Pfizer’s $10 Billion Buyout, $6 Billion Bond Sale and What It Means for Investors

Pfizer has closed its up to $10 billion acquisition of Metsera (MTSR) and raised $6 billion in bonds to help fund the deal. Here’s what today’s developments mean for former Metsera shareholders, Pfizer investors and the future of the obesity drug market. What Happened Today: Pfizer Locks In $6 Billion Bond Financing The main fresh headline for 21 November 2025 is on the financing side, not on Metsera’s standalone stock — because MTSR no longer trades. German market outlet boerse‑global/ad‑hoc‑news reports that Pfizer has successfully raised $6 billion in the U.S. investment‑grade bond market to support the cash portion of
21 November 2025
···
Enviri (NVRI) Soars as It Sells Clean Earth to Veolia for $3.04 Billion and Unveils “New Enviri” Spin‑Off

Enviri (NVRI) Soars as It Sells Clean Earth to Veolia for $3.04 Billion and Unveils “New Enviri” Spin‑Off

Enviri Corporation (NYSE: NVRI) has kicked off one of the most consequential restructurings in its 170‑year history, agreeing to sell its Clean Earth hazardous‑waste business to France’s Veolia Environnement for $3.04 billion in cash and unveiling plans to spin off its remaining Harsco Environmental and Rail units into a new standalone public company dubbed “New Enviri.” Enviri+1 The deal, announced early Friday, sent NVRI stock jumping more than 30% in premarket trading, as investors digested a package that combines a sizable cash payout with shares in a less‑levered, refocused environmental and rail company. TradingView+1 Key takeaways for Enviri (NVRI) shareholders
21 November 2025
···
Ondas Holdings (ONDS) Jumps on $35M PDW Combat Robotics Deal as Sentrycs Acquisition Reshapes Drone-Defense Strategy – 21 November 2025

Ondas Holdings (ONDS) Jumps on $35M PDW Combat Robotics Deal as Sentrycs Acquisition Reshapes Drone-Defense Strategy – 21 November 2025

Today’s Headline: Ondas Pours $35M into PDW to Scale Combat Robotics The main catalyst for Ondas Holdings Inc. (ONDS) in the news cycle on 21 November 2025 is the market’s reaction to its $35 million strategic investment in Performance Drone Works (PDW), a fast‑growing U.S. defense‑technology company focused on combat robotics. Ondas Holdings Inc.+1 According to Ondas’ 20 November press release and follow‑up coverage from Investing.com, PDW: Ondas Holdings Inc.+1 Ondas says the investment will be used to: Management is framing the deal as a way to deepen Ondas’ position as a provider of AI‑enabled autonomous defense platforms, complementing its
21 November 2025
··
Abbott Laboratories (ABT) to Buy Exact Sciences in Up to $23 Billion Cancer Diagnostics Deal – All the Key News on November 20, 2025

Abbott Laboratories (ABT) to Buy Exact Sciences in Up to $23 Billion Cancer Diagnostics Deal – All the Key News on November 20, 2025

Abbott Laboratories (NYSE: ABT) shook the healthcare and medtech markets today, November 20, 2025, by announcing a definitive agreement to acquire cancer diagnostics specialist Exact Sciences Corporation (NASDAQ: EXAS) in an all‑cash transaction valuing the target at about $21 billion in equity and roughly $23 billion including debt. Reuters+2PR Newswire+2 The move marks Abbott’s largest acquisition in nearly a decade and one of the biggest healthcare deals of 2025, instantly positioning the company as a heavyweight in cancer screening and precision oncology diagnostics — markets it has largely approached from the sidelines until now. Reuters+1 As of mid‑afternoon trading, ABT
20 November 2025
··
Abbott to Acquire Exact Sciences for $21 Billion in Cancer Screening Mega-Deal

Abbott to Acquire Exact Sciences for $21 Billion in Cancer Screening Mega-Deal

Abbott has agreed to acquire cancer diagnostics specialist Exact Sciences in a cash deal valued at about $21 billion in equity, or roughly $23 billion including debt, in one of the biggest healthcare transactions of 2025 and Abbott’s largest deal in nearly a decade. Abbott MediaRoom+2Reuters+2 The transaction gives Abbott an immediate leadership position in fast‑growing cancer screening and precision oncology diagnostics, anchored by Exact Sciences’ flagship tests Cologuard and Oncotype DX, plus its new multi‑cancer blood test Cancerguard. Abbott MediaRoom+2investor.exactsciences.com+2 Deal Terms: $105 per Share and a $23 Billion Enterprise Value Under the definitive agreement announced today, Abbott will
20 November 2025
··
Spectris PLC Share Price Today (20 November 2025): LON:SXS Holds Just Below £41.75 KKR Takeover Price

Spectris PLC Share Price Today (20 November 2025): LON:SXS Holds Just Below £41.75 KKR Takeover Price

Spectris plc (LON:SXS), the precision measurement specialist and FTSE 250 constituent, continues to trade tightly around its pending takeover price as the market absorbs a fresh wave of disclosure notices and takeover‑related updates. Spectris share price today: 20 November 2025 snapshot As of Thursday 20 November 2025, Spectris PLC’s share price is trading at 4,108.0p (approximately £41.08) on the London Stock Exchange. That puts the stock up 2p (+0.05%) on the day, after opening at 4,128.0p and moving within a tight intraday range of 4,108.0p–4,128.0p. Around 236,000 shares have already changed hands, equivalent to roughly £9.5 million of stock turning over in the market. London South East Key price and valuation metrics today:
20 November 2025
·
Palo Alto Networks’ AI-Fueled Surge: Stock Soars on Cybersecurity Boom, Bold Forecasts & Big Deals

PANW Stock Today (Nov 19, 2025): Palo Alto Networks beats Q1, announces $3.35B Chronosphere deal; shares swing after hours

November 19, 2025 — Palo Alto Networks (NASDAQ: PANW) packed multiple headlines into one day: fiscal Q1 2026 results that grew double‑digits, a definitive agreement to buy observability platform Chronosphere for $3.35 billion, a board refresh, and a new quantum‑safe collaboration with IBM. PR Newswire+4PR Newswire+4Reuters+4 PANW stock price snapshot (after hours) Following the release, PANW shares whipsawed in late trading, changing hands around $199.90 as of 21:30 UTC, with an intraday range that stretched from $186.69 to $211.64 on volume of about 6.7 million shares. (Figures are real‑time/indicative and may update.) Earnings: double‑digit growth and steady guidance For the quarter ended October 31, 2025, Palo Alto Networks reported: Management guided Q2 FY26 revenue to $2.57–$2.59 billion and non‑GAAP
19 November 2025
··
Palo Alto Networks to Acquire Chronosphere for $3.35B, Bringing AI‑Scale Observability to Cortex AgentiX

Palo Alto Networks to Acquire Chronosphere for $3.35B, Bringing AI‑Scale Observability to Cortex AgentiX

Updated: November 19, 2025 SANTA CLARA, Calif. — Palo Alto Networks announced today that it has entered into a definitive agreement to acquire Chronosphere, a fast‑growing cloud‑native observability platform, in a deal valued at $3.35 billion to be paid in cash and replacement equity awards. The companies said the transaction is expected to close in the second half of Palo Alto Networks’ fiscal 2026, pending customary regulatory approvals. PR Newswire+1 Why this deal matters Palo Alto Networks plans to pair Chronosphere’s high‑volume, cost‑efficient telemetry pipeline with its Cortex AgentiX platform to move beyond monitoring dashboards toward real‑time, agentic remediation—where AI agents can detect issues, investigate root causes, and autonomously fix
19 November 2025
···
EXAS Stock Soars on Abbott Takeover Talks: Exact Sciences Jumps Over 20% on November 19, 2025

EXAS Stock Soars on Abbott Takeover Talks: Exact Sciences Jumps Over 20% on November 19, 2025

Exact Sciences Corporation (NASDAQ: EXAS) is surging today after reports that healthcare giant Abbott Laboratories is in advanced talks to acquire the cancer diagnostics specialist. Shares of EXAS spiked sharply intraday, briefly approaching new 52‑week highs as traders rushed into the name on renewed takeover speculation. Reuters+2Investing.com+2 Key points EXAS stock today: price, move, and trading activity According to Exact Sciences’ own investor relations quote page, EXAS was recently quoted at $81.79, up $12.11 or +17.38% versus yesterday’s close at $69.68. Intraday, the stock has traded between $69.11 and $89.67, with volume already above 10.4 million shares, far exceeding its recent averages. investor.exactsciences.com+1 Other real‑time feeds and market reports
19 November 2025
·
Abbott (ABT) Stock Slides on Mixed Q3 Results – Is a Rally Over?

Abbott Nears Takeover of Exact Sciences, Sending Cancer Test Maker’s Stock Soaring on November 19, 2025

Abbott Laboratories is in advanced talks to acquire cancer diagnostics specialist Exact Sciences, in what could be the healthcare giant’s largest deal in nearly a decade and a major shake-up for the global cancer testing market.Bloomberg+1 Abbott in Talks for Biggest Deal in Nearly a Decade On Wednesday, November 19, 2025, multiple outlets reported that Abbott Laboratories is close to a deal to buy Exact Sciences Corp., a U.S.-based molecular diagnostics company best known for its Cologuard colorectal cancer screening test. Bloomberg+1 According to people familiar with the matter cited by Bloomberg, Abbott is negotiating the terms of a transaction with
19 November 2025
·
Semrush Stock Soars 75% Today as Adobe Announces $1.9 Billion Cash Takeover – What SEMR Investors Need to Know (19 November 2025)

Semrush Stock Soars 75% Today as Adobe Announces $1.9 Billion Cash Takeover – What SEMR Investors Need to Know (19 November 2025)

Semrush Holdings, Inc. (NYSE: SEMR) is one of the hottest stocks in the market today after Adobe unveiled a definitive agreement to acquire the AI‑driven marketing and SEO platform in a $1.9 billion all‑cash deal.Adobe Newsroom+1 As of the latest trade this afternoon on 19 November 2025, Semrush shares are changing hands around $11.8, up roughly 74% on the day, after trading between about $6.82 and $11.87 in today’s session.Timothy Sykes+1 Below is a full breakdown of what happened today, what’s in the Adobe–Semrush deal, how the offer compares to Semrush’s fundamentals and history, and what it all means for SEMR stock holders. Semrush Stock Price Today: SEMR Explodes on
19 November 2025
·
Ondas Holdings (ONDS) Stock in Focus After Sentrycs Acquisition, Airport Defense Deal and Record Q3 2025 Earnings – November 19, 2025

Ondas Holdings (ONDS) Stock in Focus After Sentrycs Acquisition, Airport Defense Deal and Record Q3 2025 Earnings – November 19, 2025

Ondas Holdings Inc. (NASDAQ: ONDS) remains one of the most talked‑about small‑cap defense and drone stocks this month. After a blistering rally driven by record third‑quarter results and a flurry of acquisitions, the stock is consolidating on Wednesday, November 19, 2025, as fresh research notes highlight both its explosive growth and its continuing risks. By mid‑afternoon, ONDS shares were trading around $7.77, down slightly on the day but still up dramatically from their 52‑week low of about $0.57, giving the company a market value just under $3 billion. Stocktwits ONDS stock today: cooling after a parabolic run Even with today’s
19 November 2025
···
Dycom Industries (DY) Soars on Earnings Beat, Higher 2026 Outlook and $1.95 Billion Data‑Center Acquisition

Dycom Industries (DY) Soars on Earnings Beat, Higher 2026 Outlook and $1.95 Billion Data‑Center Acquisition

Dycom Industries, Inc. (NYSE: DY) is firmly in the market spotlight today after reporting record fiscal 2026 third‑quarter results, raising its full‑year guidance and unveiling a $1.95 billion deal to acquire Power Solutions, a major data‑center electrical contractor.GlobeNewswire+1 Record Q3 2026 Results: Revenue, Earnings and Backlog All Hit New Highs For the quarter ended October 25, 2025, Dycom delivered one of the strongest prints in its history: The company’s backlog — a key indicator of future revenue — reached a record $8.2 billion as of quarter‑end, highlighting strong multi‑year visibility across its telecom and digital‑infrastructure customers.GlobeNewswire+1 In a statement, CEO
19 November 2025
·
Blue Owl Capital (OWL) Scraps OBDC–OBDC II Merger as Redemption Freeze Roils the $3 Trillion Private Credit Market

Blue Owl Capital (OWL) Scraps OBDC–OBDC II Merger as Redemption Freeze Roils the $3 Trillion Private Credit Market

Alternative asset manager Blue Owl Capital Inc. (NYSE: OWL) has pulled the plug on a controversial merger of two of its private-credit funds, capping a tumultuous week that has turned one mid‑size Wall Street firm into the poster child for growing stress in private credit. On Wednesday, Blue Owl Capital Corporation (NYSE: OBDC) and Blue Owl Capital Corporation II (OBDC II) said they have terminated their planned merger, just weeks after announcing it, citing “current market conditions” and a desire to protect shareholders.PR Newswire+1 The reversal comes after: Here’s what changed today, why it matters, and what investors in OWL
19 November 2025
Warner Bros. Discovery (WBD) Stock Soars as $70 Billion‑Plus Takeover Race Heats Up – Paramount, Netflix & Comcast Face Bid Deadline

Warner Bros. Discovery (WBD) Stock Soars as $70 Billion‑Plus Takeover Race Heats Up – Paramount, Netflix & Comcast Face Bid Deadline

Warner Bros. Discovery, Inc. (NASDAQ: WBD) is at the center of one of the biggest media takeover battles in years, with Hollywood studios, tech streamers and Gulf sovereign wealth funds all circling the owner of HBO, CNN and the DC Universe. As first‑round bids are due on 20 November, Warner Bros. Discovery’s board is pushing for a higher price, investors are piling into the stock and new reports keep reshaping the narrative almost by the hour. Reuters+1 At early afternoon trading today, WBD shares traded around $23.69, up just over 4% on the day, giving the company a market capitalization
19 November 2025
·
Cheer Holding (NASDAQ: CHR) Stock Today: Tiny AI Metaverse Player Weighs Two Takeover Bids as Shares Spike Pre‑Market

Cheer Holding (NASDAQ: CHR) Stock Today: Tiny AI Metaverse Player Weighs Two Takeover Bids as Shares Spike Pre‑Market

Cheer Holding, Inc. (NASDAQ: CHR) is back on traders’ radar today after a fresh wave of headlines around a potential buyout and another burst of pre‑market volatility in its penny‑stock shares. The Beijing‑based mobile internet and AI company has formed a special committee to evaluate two competing cash offers for all of its Class A shares, while the stock continues to trade below 5 cents. Stock Titan+2Investing.com+2 Key takeaways What happened: Cheer Holding forms Special Committee to consider buyout proposals On November 18, 2025, Cheer Holding announced that its board of directors had created a Special Committee of “disinterested” directors
19 November 2025
····
Kenvue (KVUE) Stock Plunges Amid Tylenol and Talc Fears – What’s Next?

KVUE Stock Today (Nov. 18, 2025): Shares Slip as Appeals Court Weighs Tylenol Cases; Dividend Cleared; Kimberly‑Clark Deal Spread Persists

At a glance — price & drivers (midday, Nov. 18, 2025) Market action and context KVUE softened today after Monday’s developments in federal litigation tied to claims that prenatal acetaminophen use raises autism risk. A three‑judge appeals panel questioned the lower court’s dismissal of those cases, opening the door to their potential return and keeping headline risk front‑and‑center for the stock. Reuters Overnight and early‑morning coverage underscored the legal pressure, noting KVUE fell as the court weighed revival of the suits—sentiment that carried into today’s trading. Bloomberg Law Dividend: payout still on track for Nov. 26 In a separate Texas
18 November 2025
···
Is Warner Bros. Discovery (WBD) the Next Big Media Stock? 75% YTD Surge Sparks Buzz

WBD Stock Today: Warner Bros. Discovery Near 52-Week High as Sale Bids Heat Up (November 18, 2025)

Snapshot: WBD stock on November 18, 2025 Warner Bros. Discovery (NASDAQ: WBD) spent Tuesday trading just under its recent highs as Wall Street digested a wave of fresh headlines about a potential sale of the company and looming bid deadlines this week. As of the latest afternoon quote on November 18: In other words, today’s modest move is happening near the very top of WBD’s 52‑week range, with the stock having more than doubled from its 2024 lows as takeover speculation and restructuring plans reshaped the investment story. All of this is playing out against a weak broader tape: major
18 November 2025
·
Barrick Mining Stock Jumps as Elliott’s $700 Million Stake Fuels Breakup Speculation – 18 November 2025

Barrick Mining Stock Jumps as Elliott’s $700 Million Stake Fuels Breakup Speculation – 18 November 2025

Barrick Mining stock (NYSE: B, TSX: ABX) climbed on November 18, 2025 after activist fund Elliott Investment Management built a top‑10 stake, intensifying talk of a potential breakup and fresh deals in Québec. Elliott Investment Management Moves In Barrick Mining Corporation’s stock was back in the spotlight today, 18 November 2025, after reports that activist investor Elliott Investment Management has quietly built a major position in the Canadian gold and copper giant. According to Reuters, Elliott has accumulated a “significant stake” in Barrick Mining (TSX: ABX), large enough to rank the fund among the miner’s ten biggest shareholders. Reuters Reporting from the Financial Times, cited
18 November 2025
Click Holdings (CLIK) Jumps After Acquiring Two Hong Kong HR Firms – What Investors Need to Know Today

Click Holdings (CLIK) Jumps After Acquiring Two Hong Kong HR Firms – What Investors Need to Know Today

Micro‑cap HR and senior‑care stock spikes again as it inks two all‑stock deals and leans into its AI and “Silver Economy” strategy. Click Holdings (NASDAQ: CLIK) stock is moving sharply on November 18, 2025 after announcing all‑stock acquisitions of Bowser Human Resources and Top Team Consultants in Hong Kong. Here’s what’s driving the rally, how dilutive the deal is, and what investors should watch next. Key takeaways Click Holdings stock pops again as it buys two Hong Kong HR firms On November 18, 2025, shares of Click Holdings Limited (CLIK) continued their sharp move higher after the company disclosed two
18 November 2025
·
1 … 11 12 13 14 15 … 20

Stock Market Today

Home Depot stock price: jobs, inflation and a Feb. 24 earnings test loom

Home Depot stock price: jobs, inflation and a Feb. 24 earnings test loom

7 February 2026
Home Depot shares rose 0.7% to $385.15 Friday, trading between $379.10 and $386.37. Investors await a delayed U.S. jobs report Wednesday and CPI data Friday, both postponed by a brief government shutdown. Home Depot reports fourth-quarter earnings Feb. 24. The Dow closed above 50,000 for the first time.
JPMorgan stock price jumps 4% into weekend as Wall Street braces for a busy data week

JPMorgan stock price jumps 4% into weekend as Wall Street braces for a busy data week

7 February 2026
JPMorgan shares rose 3.95% to $322.40 Friday, outpacing other major banks as U.S. stocks rallied and the Dow closed above 50,000 for the first time. The bank recently completed a $3 billion subordinated notes offering. Investors are watching for delayed U.S. jobs data and inflation figures next week, ahead of JPMorgan’s Feb. 23 company update.
AbbVie stock price: ABBV ends week near $223 after earnings swing — what to watch next

AbbVie stock price: ABBV ends week near $223 after earnings swing — what to watch next

7 February 2026
AbbVie shares rose 2% to $223.43 Friday, capping a volatile week marked by earnings and drug sales scrutiny. Moody’s upgraded AbbVie’s credit rating to A2, citing strong performance in immunology and neuroscience. Investors remain focused on Skyrizi and Rinvoq growth amid rising competition and recent regulatory filings. Trading volume stayed below average, with the stock still 9% off its 52-week high.
SK hynix stock price slips into Monday after S&P upgrade, tech selloff

SK hynix stock price slips into Monday after S&P upgrade, tech selloff

7 February 2026
SK hynix shares closed at 839,000 won, down 0.36% Friday and 8% for the week, as tech stocks retreated across Asia. S&P Global Ratings upgraded the chipmaker to “BBB+” with a positive outlook, citing strong HBM sales. The KOSPI fell 1.4% Friday, ending a six-week winning streak. Traders await Monday’s Seoul open for signs of further tech weakness.
Go toTop